Waypoint Capital Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$275K Sell
2,425
-139
-5% -$16.5K 0.06% 109
2024
Q2
$317K Buy
2,564
+137
+6% +$17.6K 0.08% 102
2024
Q1
$320K Buy
2,427
+83
+4% +$10.2K 0.08% 101
2023
Q4
$256K Hold
2,344
0.07% 106
2023
Q3
$241K Buy
2,344
+111
+5% +$12K 0.08% 106
2023
Q2
$258K Buy
2,233
+67
+3% +$7.61K 0.08% 125
2023
Q1
$230K Hold
2,166
0.08% 123
2022
Q4
$240K Buy
+2,166
New +$221K 0.08% 122
2022
Q3
Sell
-2,542
Closed -$232K 115
2022
Q2
$232K Sell
2,542
-35
-1% -$3.1K 0.11% 103
2022
Q1
$210K Buy
+2,577
New +$203K 0.12% 109

Other funds holding MRK

Waypoint Capital Advisors's MRK Position: Q3 2024 in Review

Waypoint Capital Advisors reduced its Merck (MRK) stake by 5.4% in Q3 2024, selling an estimated $16.5K and leaving 2,425 shares worth $275K. The position accounts for 0.06% of the portfolio, ranked #109.

Waypoint Capital Advisors first reported a position in MRK in Q1 2022 and has held it in 10 quarters since. The position peaked at $320K in Q1 2024. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Waypoint Capital Advisors held 2,425 shares of Merck worth $275K as of Q3 2024.
  • Waypoint Capital Advisors sold 139 Merck shares in Q3 2024, an estimated $16.5K.
  • Merck made up 0.06% of Waypoint Capital Advisors's portfolio in Q3 2024, its #109 holding.
  • Waypoint Capital Advisors first reported a position in Merck in Q1 2022 and has held it in 10 quarters since.
  • Waypoint Capital Advisors's Merck position peaked at $320K in Q1 2024.
  • 3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Waypoint Capital Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.